Natixis Advisors LLC Sells 11,132 Shares of The Cigna Group (NYSE:CI)

Natixis Advisors LLC cut its stake in The Cigna Group (NYSE:CI - Free Report) by 3.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 360,888 shares of the health services provider's stock after selling 11,132 shares during the period. Natixis Advisors LLC owned approximately 0.13% of The Cigna Group worth $125,026,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Avantax Advisory Services Inc. lifted its stake in The Cigna Group by 8.5% during the first quarter. Avantax Advisory Services Inc. now owns 3,612 shares of the health services provider's stock worth $1,312,000 after purchasing an additional 284 shares during the last quarter. Lord Abbett & CO. LLC lifted its stake in shares of The Cigna Group by 43.9% in the 1st quarter. Lord Abbett & CO. LLC now owns 3,969 shares of the health services provider's stock valued at $1,441,000 after acquiring an additional 1,211 shares during the last quarter. Banco Santander S.A. increased its holdings in The Cigna Group by 379.4% in the 1st quarter. Banco Santander S.A. now owns 7,153 shares of the health services provider's stock worth $2,598,000 after purchasing an additional 5,661 shares in the last quarter. M&G Plc bought a new position in The Cigna Group in the first quarter valued at about $8,648,000. Finally, Mizuho Markets Americas LLC bought a new stake in shares of The Cigna Group during the first quarter worth about $4,389,000. 86.99% of the stock is currently owned by institutional investors.

The Cigna Group Stock Down 0.7 %

The Cigna Group stock traded down $2.36 during midday trading on Friday, hitting $321.52. 1,650,180 shares of the stock were exchanged, compared to its average volume of 1,545,534. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $89.43 billion, a price-to-earnings ratio of 30.33, a price-to-earnings-growth ratio of 1.00 and a beta of 0.51. The Cigna Group has a 52-week low of $253.95 and a 52-week high of $370.83. The business's 50-day moving average price is $338.88 and its 200-day moving average price is $339.67.

The Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. During the same period last year, the firm posted $6.77 EPS. The business's revenue was up 29.8% compared to the same quarter last year. On average, research analysts expect that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.74%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group's dividend payout ratio (DPR) is currently 52.83%.

Insider Activity at The Cigna Group

In related news, Director William J. Delaney III sold 2,691 shares of the business's stock in a transaction on Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now directly owns 17,539 shares in the company, valued at approximately $6,010,264.52. The trade was a 13.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CI. Jefferies Financial Group upped their price target on shares of The Cigna Group from $402.00 to $422.00 and gave the company a "buy" rating in a research report on Tuesday, September 17th. StockNews.com downgraded The Cigna Group from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. Royal Bank of Canada dropped their price target on shares of The Cigna Group from $384.00 to $377.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a "buy" rating for the company in a research report on Monday, November 4th. One research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $394.64.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.